SynthesisPeerJ2025
Synergistic effects of virtual reality and traditional treatment methods in the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects of Virtual Reality Interventions on Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.International journal of chronic obstructive pulmonary disease · 2026Pooled it
- "Your Digital Doctor Will Now See You": A Narrative Review of VR and AI Technology in Chronic Illness Management.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the synergistic effects of virtual reality (VR) combined with traditional therapies in the treatment of chronic obstructive pulmonary disease (COPD). Methods: A systematic review was conducted to identify relevant randomized controlled trials (RCTs) evaluating the effects of VR combined with conventional therapy on lung function, exercise tolerance, quality of life, and mental health in patients with COPD. Two researchers independently screened the literature, extracted data, and assessed study quality. A meta-analysis was performed on the outcome measures. Results: Included 15 RCTs (eight from China, three from Poland, one from Turkey, one from Indonesia, and two from Italy), involving a total of 809 COPD patients (published between 2014 and 2024). All studies demonstrated significant improvements in at least one aspect (lung function, mental health, or quality of life). The meta-analysis showed that VR-based therapy significantly improved the 6-min walk test (6MWT), forced expiratory volume in 1 s (FEV1/FVC), and the Hospital Anxiety and Depression Scale (HADS). High heterogeneity was observed for FEV1% predicted, COPD Assessment Test (CAT), and modified Medical Research Council Dyspnea Scale (mMRC); subgroup analyses suggested that intervention duration and single-session duration were potential contributing factors. Conclusion: VR combined with traditional therapy has significant advantages over traditional therapy alone, with synergistic effects that can improve lung function and exercise endurance in COPD patients, alleviate psychological problems such as anxiety and depression, and enhance quality of life. Although the effects are significant, future research is needed to verify its clinical relevance (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.